BNIP3

Chr 10

BCL2 interacting protein 3

Also known as: HABON, NIP3

This gene encodes a mitochondrial pro-apoptotic protein that induces cell death by overcoming BCL2 suppression and participates in mitochondrial quality control by facilitating degradation of damaged mitochondrial proteins. The gene shows very low constraint against loss-of-function variants (pLI near 0, LOEUF 1.46), suggesting loss of function is well-tolerated in the general population. No established Mendelian diseases have been definitively linked to BNIP3 mutations in the pediatric population.

Summary from RefSeq, UniProt
Research Assistant →
1
Active trials
274
Pubs (1 yr)
96
P/LP submissions
0%
P/LP missense
1.46
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryBNIP3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
96 unique Pathogenic / Likely Pathogenic· 33 VUS of 135 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.46LOEUF
pLI 0.000
Z-score 0.53
OE 0.82 (0.481.46)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.83Z-score
OE missense 0.78 (0.660.93)
90 obs / 114.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.82 (0.481.46)
00.351.4
Missense OE0.78 (0.660.93)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 8 / 9.8Missense obs/exp: 90 / 114.9Syn Z: 0.30
DN
0.77top 25%
GOF
0.6541th %ile
LOF
0.3744th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

135 submitted variants in ClinVar

Classification Summary

Pathogenic91
Likely Pathogenic5
VUS33
Likely Benign1
91
Pathogenic
5
Likely Pathogenic
33
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
91
0
91
Likely Pathogenic
0
0
5
0
5
VUS
0
23
10
0
33
Likely Benign
0
0
1
0
1
Benign
0
0
0
0
0
Total0231070130

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

BNIP3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Literature
Open Research Assistant →